Cited by 324Systemic Lupus Erythematosus ResearchVenous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis Mechanisms

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies

Ruiz‐Irastorza, Guillermo, Hunt, Beverley J., Khamashta, Munther A.·2007·Arthritis Care & Research

DOI 10.1002/art.23109

Open this paper in CoChat — free account

Abstract

OBJECTIVE: To systematically review the efficacy and safety data of different therapeutic approaches in patients with antiphospholipid antibodies (aPL) and thrombosis. METHODS: The Medline database and references from selected reports and review articles were used. Randomized controlled trials, prospective and retrospective cohort studies, and subgroup analysis (n > 15) that focused on the secondary thromboprophylaxis in patients with aPL were selected. RESULTS: Sixteen studies were selected. Patients with venous events and a single test for aPL showed a low recurrence rate while receiving oral anticoagulation at a target international normalized ratio (INR) of 2.0-3.0. Patients with stroke and a single positive aPL test had no increased risk compared with those without aPL. Recurrence rates in patients with definite antiphospholipid syndrome (APS) and previous venous thromboembolism were lower than in patients with arterial and/or recurrent events, both with and without therapy. Only 3.8% of recurrent events occurred at an actual INR >3.0. Mortality due to recurrent thrombosis was higher than mortality due to bleeding (18 patients versus 1 patient reported). CONCLUSION: For patients with definite APS, we recommend prolonged warfarin therapy at a target INR of 2.0-3.0 in APS patients with first venous events and >3.0 for those with recurrent and/or arterial events. For patients with venous thromboembolism or stroke and a single positive aPL test, we recommend further testing to determine if they have a persisting antibody. If they do not, the same therapy as for the general population should be used (warfarin at a target INR of 2.0-3.0 and low-dose aspirin, respectively).

Integrity signals

Registry

Crossref · 10.1002/art.23109

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients
Cervera, R., Piette, J., Font, J., Khamashta, M. A., Shoenfeld, Y., Camps, M. T., Jacobsen, S., Lakos, G., Tincani, A., Kontopoulou‐Griva, I., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10187 · Cited by 2,156
Antithrombotic Therapy for Venous Thromboembolic Disease
Hyers, T. M., Agnelli, G., Hull, R. D., Morris, T. A., Samama, M. M., Tapson, V. F., & Weg, J. G. (2001) · CHEST Journal · doi:10.1378/chest.119.1_suppl.176s · Cited by 2,035
The management of thrombosis in the antiphospholipid-antibody syndrome
Khamashta, M. A., Cuadrado, M. J., Mujic, F., Taub, N. A., Hunt, B. J., & Hughes, G. R. V. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504133321504 · Cited by 1,450
Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT)
Palareti, G., Leali, N., COCCHERI, S., Poggi, M., Manotti, C., D’Angelo, A., Pengo, V., Erba, N., Moia, M., CIAVARELLA, N., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)01109-9 · Cited by 1,319
Antithrombotic Therapy for Venous Thromboembolic Disease
Büller, H. R., Agnelli, G., Hull, R. D., Hyers, T. M., Prins, M. H., & Raskob, G. E. (2004) · Chest · doi:10.1378/chest.126.3_suppl.401s · Cited by 1,249
Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines
Guyatt, G., Gutterman, D., Baumann, M. H., Addrizzo-Harris, D., Hylek, E. M., Phillips, B., Raskob, G., Lewis, S. Z., & Schünemann, H. (2006) · Chest · doi:10.1378/chest.129.1.174 · Cited by 1,220
A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke
Mohr, J. P., Thompson, J. L. P., Lazar, R. M., Levin, B., Sacco, R. L., Furie, K. L., Kistler, J. P., Albers, G. W., Pettigrew, L. C., Adams, H. P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011258 · Cited by 1,168
Hemorrhagic Complications of Anticoagulant Treatment
Levine, M. N., Raskob, G. E., Landefeld, S., & Kearon, C. (2001) · CHEST Journal · doi:10.1378/chest.119.1_suppl.108s · Cited by 1,129
A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome
Crowther, M. A., Ginsberg, J. S., Julian, J., Denburg, J., Hirsh, J., Douketis, J., Laskin, C., Fortin, P., Anderson, D., Kearon, C., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035241 · Cited by 919

Flagged first, then by citations

Show all 40 references

Sorted by citations

Items 101–200 of 323

Identification of a Monoclonal Antibody That Attenuates Antiphospholipid Syndrome-Related Pregnancy Complications and Thrombosis
Mineo, C., Lanier, L., Jung, E.-J., Sengupta, S., Ulrich, V., Sacharidou, A., Tarango, C., Osunbunmi, O., Shen, Y.-M. P., Salmon, J. E., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158757 · Cited by 28
Update on Antiphospholipid Syndrome: Ten Topics in 2017
Cavazzana, I., Andréoli, L., Limper, M. A., Franceschini, F., & Tincani, A. (2018) · Current Rheumatology Reports · doi:10.1007/s11926-018-0718-4 · Cited by 29
Acquired Thrombophilia
Armstrong, E. M., Bellone, J. M., Hornsby, L. B., Eudaley, S. T., & Phillippe, H. M. (2014) · Journal of Pharmacy Practice · doi:10.1177/0897190014530424 · Cited by 31
Cutting-Edge Issues in Coronary Disease and the Primary Antiphospholipid Syndrome
Gualtierotti, R., Biggioggero, M., & Meroni, P. L. (2011) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-011-8268-9 · Cited by 27
Update on antiphospholipid syndrome.
Lockshin, M. D. (2006) · PubMed · Cited by 27
Recomendaciones de la Sociedad Española de Reumatología sobre síndrome antifosfolípido primario. Parte I: Diagnóstico, evaluación y tratamiento
Cáliz, R., Fontecha, P. D. D. C., Galindo-Izquierdo, M., Longo, F. J. L., Zamora, M. Á. M., Santamaría, A., Pliego, O. A., Lozano, M. J. C., Beltrán, M. P. D., Carmona, L., et al. (2019) · Reumatología Clínica · doi:10.1016/j.reuma.2018.11.003 · Cited by 26
Prevalence of the Antiphospholipid Syndrome and Its Effect on Survival in 679 Chinese Patients With Systemic Lupus Erythematosus
Mok, C. C., Chan, P. T., Ho, L. Y., Yu, K. L., & To, C. H. (2013) · Medicine · doi:10.1097/md.0b013e31829cae47 · Cited by 26
APS – controversies in diagnosis and management, critical overview of current guidelines
Pengo, V. (2011) · Thrombosis Research · doi:10.1016/s0049-3848(11)70014-7 · Cited by 25
Anticoagulation therapy for prevention and treatment of venous thromboembolic events in cancer patients: A review of current guidelines
Petersen, L. J. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2009.08.009 · Cited by 25
The chequered history of the antiphospholipid syndrome
Arachchillage, D. J., & Greaves, M. (2014) · British Journal of Haematology · doi:10.1111/bjh.12848 · Cited by 25
A retrospective review of pediatric antiphospholipid syndrome and thrombosis outcomes
Rao, A. A. N., Elwood, K., Kaur, D., Warad, D., & Rodriguez, V. (2016) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0000000000000576 · Cited by 27
Prevention of thrombosis in antiphospholipid syndrome
Lim, W. (2016) · Hematology · doi:10.1182/asheducation-2016.1.707 · Cited by 25
What is the appropriate anticoagulation strategy for thrombotic antiphospholipid syndrome?
Arachchillage, D. J., & Laffan, M. (2020) · British Journal of Haematology · doi:10.1111/bjh.16431 · Cited by 26
The treatment of antiphospholipid syndrome: A harmonic contrast
Ruiz‐Irastorza, G., & Khamashta, M. A. (2007) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2007.10.003 · Cited by 23
Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myeloma
Green, D. J., Maloney, D. G., Storer, B. E., Sandmaier, B. M., Holmberg, L. A., Becker, P. S., Fang, M., Martin, P. J., Georges, G. E., Bouvier, M. E., et al. (2017) · Blood Advances · doi:10.1182/bloodadvances.2017010686 · Cited by 23
Loss of antiphospholipid antibody positivity post-thrombosis in SLE
Khawaja, M., Magder, L. S., GOLDMAN, D. W., & Petri, M. (2020) · Lupus Science & Medicine · doi:10.1136/lupus-2020-000423 · Cited by 22
The incidence and risk factors of recurrent venous thromboembolism during pregnancy
Galambosi, P. J., Ulander, V., & Kaaja, R. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.04.026 · Cited by 22
Recent Advances in Anticoagulant Treatment of Immune Thrombosis: A Focus on Direct Oral Anticoagulants in Heparin-Induced Thrombocytopenia and Anti-Phospholipid Syndrome
Carré, J., Jourdi, G., Gendron, N., Helley, D., Gaussem, P., & Darnige, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010093 · Cited by 22
Anticoagulant and non-anticoagulant therapy in thrombotic antiphospholipid syndrome: old drugs and new treatment targets
Ruiz‐Irastorza, G., Tektonidou, M. G., & Khamashta, M. A. (2024) · Rheumatology · doi:10.1093/rheumatology/kead538 · Cited by 22
The risk of ischemic stroke in major rheumatic disorders
Behrouz, R. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.09.009 · Cited by 20
Diretrizes para o tratamento da síndrome do anticorpo antifosfolipídeo
Danowski, A., Rêgo, J., Kakehasi, A. M., Funke, A., de Carvalho, J. F., Lima, I., de Souza, A. W. S., & Levy, R. A. (2013) · Revista Brasileira de Reumatologia · doi:10.1590/s0482-50042013000200005 · Cited by 21
Guidelines for the treatment of antiphospholipid syndrome
Danowski, A., Rêgo, J., Kakehasi, A. M., Funke, A., de Carvalho, J. F., Lima, I., de Souza, A. W. S., & Levy, R. A. (2013) · Revista Brasileira de Reumatologia (English Edition) · doi:10.1016/s2255-5021(13)70021-x · Cited by 19
Vitamin K Antagonists – Current Concepts and Challenges
Moualla, H., & Garcia, D. A. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.04.011 · Cited by 19
Neurolupus (1re partie). Description et démarche diagnostique et thérapeutique dans les manifestations neurologiques centrales et psychiatriques au cours du lupus érythémateux systémique
Lefèvre, G., Zéphir, H., Warembourg, F., Michelin, E., Pruvo, J., HACHULLA, E., Semah, F., Dubucquoi, S., Lenfant, P., Vermersch, P., et al. (2012) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2012.03.356 · Cited by 18
Antiphospholipid syndrome presenting as cerebral venous sinus thrombosis: a case series and a review
Shlebak, A. A. (2015) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2015-203077 · Cited by 19
Lung Disease in Antiphospholipid Syndrome
Maioli, G., Calabrese, G., CAPSONI, F., Gerosa, M., Meroni, P. L., & Chighizola, C. B. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1683994 · Cited by 18
Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? Yes (in some cases)
Gerosa, M., Chighizola, C. B., & Meroni, P. L. (2008) · Internal and Emergency Medicine · doi:10.1007/s11739-008-0170-y · Cited by 18
Venous thromboembolic disease in systemic autoimmune diseases: An association to keep in mind
Silvariño, R., Danza, Ã., Mérola, V., Bérez, A., Méndez, E., Espinosa, G., & Cervera, R. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.05.002 · Cited by 18
Risk Factors for the Development of the Disease in Antiphospholipid Antibodies Carriers: A Long-term Follow-up Study
Pablo, R. Q., Muñoz, P., López‐Hoyos, M., Calvo-Río, V., Riancho‐Zarrabeitia, L., & Martínez-Taboada, V. M. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-021-08862-5 · Cited by 18
Thromboprophylaxis and obstetric management of the antiphospholipid syndrome
Espinosa, G., & Cervera, R. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560902772302 · Cited by 16
Reduced plasma fibrin clot permeability is associated with recurrent thromboembolic events in patients with antiphospholipid syndrome
Celińska‐Löwenhoff, M., Ząbczyk, M., Iwaniec, T., Plens, K., Musiał, J., & Undas, A. (2018) · Rheumatology · doi:10.1093/rheumatology/key089 · Cited by 17
Direct Oral Anticoagulants for Thromboprophylaxis in Patients with Antiphospholipid Syndrome
Efthymiou, M., Gates, C., Isenberg, D. A., & Cohen, H. (2017) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0036-1597902 · Cited by 16
Reviewing the Recommendations for Lupus in Children
Arıcı, Z. S., Batu, E. D., & Özen, S. (2015) · Current Rheumatology Reports · doi:10.1007/s11926-014-0489-5 · Cited by 17
Therapeutic strategies in severe neuropsychiatric systemic lupus erythematosus: experience from a tertiary referral centre
Bortoluzzi, A., J, M. P. J., Farina, I., Galuppi, E., Leonardis, F. D., & Govoni, M. (2012) · Reumatismo · doi:10.4081/reumatismo.2012.350 · Cited by 16
Clinical Aspects of the Nervous System
West, S. G. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1893-5.00029-7 · Cited by 16
A retrospective study of pulmonary infarction in patients with systemic lupus erythematosus from southern Taiwan
Weng, C. T., Chung, T., Liu, M. F., Weng, M.-Y., Lee, C., Chen, J., Wu, A. W. B. S., Lin, B., Luo, C., Hsu, S., et al. (2011) · Lupus · doi:10.1177/0961203311401458 · Cited by 16
Guia de Practica Clinica
chilena, A. L., Eritematoso, L., Sistémico, Malo, M. Á., & de Gobernanza, V. (2013) · Cited by 15
Broad Concepts in Management of Systemic Lupus Erythematosus
CHOWDHARY, V. R. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.02.007 · Cited by 15
Antibodies against TFPI and protein C are associated with a severe thrombotic phenotype in patients with and without antiphospholipid syndrome
Efthymiou, M., Arachchillage, D. J., Lane, P. J., O’Keeffe, A. G., McDonnell, T. C. R., Cohen, H., & Mackie, I. J. (2018) · Thrombosis Research · doi:10.1016/j.thromres.2018.08.003 · Cited by 15
Management of antiphospholipid syndrome
Papa, N. D., & Vaso, N. (2010) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x10365969 · Cited by 15
Morbidity and mortality in the antiphospholipid syndrome
Espinosa, G., & Cervera, R. (2009) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e32832d0463 · Cited by 15
Management of antiphospholipid syndrome
Rahman, A. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05183-4 · Cited by 18
Antiphospholipid Syndrome: State of the Art of Clinical Management
Depietri, L., Veropalumbo, M. R., Leone, M. C., & Ghirarduzzi, A. (2023) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-023-07496-3 · Cited by 16
Management of Cardiovascular Complications in Antiphospholipid Syndrome: A Narrative Review with a Focus on Older Adults
Bernardi, M., Spadafora, L., Andaloro, S., Piscitelli, A., Fornaci, G., Intonti, C., Fratta, A. E., Hsu, C.-E., Kaziród-Wolski, K., Metsovitis, T., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13113064 · Cited by 16
Duration of anticoagulation after initial idiopathic venous thrombosis – the swinging pendulum: Risk assessment to predict recurrence
Eichinger, S., & Kyrle, P. A. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03383.x · Cited by 14
Management of anticoagulant-refractory thrombotic antiphospholipid syndrome
Cohen, H., Sayar, Z., Efthymiou, M., Gaspar, P., Richards, T., & Isenberg, D. A. (2020) · The Lancet Haematology · doi:10.1016/s2352-3026(20)30116-2 · Cited by 17
Hydroxychloroquine : une nouvelle approche thérapeutique des manifestations thrombotiques du syndrome des antiphospholipides
Szymezak, J., Ankri, A., Fischer, A., & Darnige, L. (2010) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2010.08.018 · Cited by 14
Antiphospholipid Syndrome Review
Eby, C. (2009) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2009.06.001 · Cited by 14
Increased warfarin consumption and residual fibrin turnover in thrombotic patients with primary antiphospholipid syndrome
Ames, P. R. J., Margaglione, M., Ciampa, A., Colaizzo, D., Ferrara, F., Iannaccone, L., & VincenzoBrancaccio (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.01.014 · Cited by 14
Prevention of Recurrent Thrombosis in Antiphospholipid Syndrome: Different from the General Population?
Legault, K., Ugarte, A., Crowther, M. A., & Ruiz‐Irastorza, G. (2016) · Current Rheumatology Reports · doi:10.1007/s11926-016-0573-0 · Cited by 14
Management of women with systemic lupus erythematosus
Chugh, P. K. (2013) · Maturitas · doi:10.1016/j.maturitas.2013.03.019 · Cited by 13
Thrombosis and Anti-phospholipid Syndrome: a 5-Year Update on Treatment
Chighizola, C. B., & Meroni, P. L. (2018) · Current Rheumatology Reports · doi:10.1007/s11926-018-0741-5 · Cited by 13
Secondary prevention in thrombotic antiphospholipid syndrome
Pengo, V., Denas, G., Banzato, A., Bison, E., Bracco, A., Facchinetti, M., Hoxha, A., & Ruffatti, A. (2012) · Lupus · doi:10.1177/0961203312444773 · Cited by 12
Antiphospholipid syndrome in pediatric patients
Tarango, C., & Palumbo, J. S. (2019) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000523 · Cited by 12
Dendritic Cells and Antiphospholipid Syndrome: An Updated Systematic Review
Tang, K., Chen, H., Chen, T., Bracci, N. R., & Lin, C. (2021) · Life · doi:10.3390/life11080801 · Cited by 12
The Therapeutic Value of Laboratory Testing for Hypercoagulable States in Secondary Stroke Prevention
Kalaria, C., & Kittner, S. J. (2015) · Neurologic Clinics · doi:10.1016/j.ncl.2015.01.003 · Cited by 12
Traitement du syndrome des anticorps antiphospholipides
Saadoun, D., Pietté, J. C., Wahl, D. G., & Costedoat-Chalumeau, N. (2012) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2012.01.007 · Cited by 12
Therapeutic challenges after successful thrombectomy in a patient with an antiphospholipid syndrome associated M1-occlusion: A case report
Stadler, K., Mutzenbach, J. S., Kalss, G., Sellner, J., Al-Schameri, A. R., Trinka, E., & Killer‐Oberpfalzer, M. (2015) · Interventional Neuroradiology · doi:10.1177/1591019915590371 · Cited by 12
Latest advances in connective tissue disorders
Rao, V., & Bowman, S. (2013) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x13480280 · Cited by 13
Crassolide Suppresses Dendritic Cell Maturation and Attenuates Experimental Antiphospholipid Syndrome
Lin, C., Chang, Y., Lin, S., Su, J., Chao, Y., & Tang, K. (2021) · Molecules · doi:10.3390/molecules26092492 · Cited by 11
The presence of non-criteria manifestations negatively affects the prognosis of seronegative antiphospholipid syndrome patients: a multicenter study
da Rosa, G. P., Sousa‐Pinto, B., Ferreira, E., Araújo, O., Barilaro, G., Bettencourt, P., Cervera, R., & Espinosa, G. (2022) · Arthritis Research & Therapy · doi:10.1186/s13075-021-02702-9 · Cited by 11
Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation
Tzoran, I., Papadakis, M., Brenner, B., Fidalgo, Á., Rivas, A., Wells, P. S., Gavín, O., Adarraga, M. D., Moustafa, F., Monréal, M., et al. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2016.11.016 · Cited by 11
Biological markers of high risk of thrombotic recurrence in patients with antiphospholipid syndrome: A literature review
Lambert, M., Brodovitch, A., Mège, J., Bertin, D., & Bardin, N. (2024) · Autoimmunity Reviews · doi:10.1016/j.autrev.2024.103585 · Cited by 10
Intensidade da anticoagulação no tratamento da trombose na síndrome antifosfolípide: meta‐análise
da Silva, F. F., & de Carvalho, J. F. (2014) · Revista Brasileira de Reumatologia · doi:10.1016/j.rbr.2014.08.016 · Cited by 10
Oxford Desk Reference: Rheumatology
Hall, F. C., & Marshall, T. (2009) · Oxford University Press eBooks · doi:10.1093/med/9780199229994.001.0001 · Cited by 10
Duration of Anticoagulation Treatment for Thrombosis in APS: Is It Ever Safe to Stop?
Punnialingam, S., & Khamashta, M. A. (2013) · Current Rheumatology Reports · doi:10.1007/s11926-013-0318-2 · Cited by 9
Cerebral embolism from libman–sacks endocarditis
Malvar, B., Almeida, F. M., Rebocho, L., Moniz, J., & Azevedo, F. (2011) · BMJ Case Reports · doi:10.1136/bcr.04.2011.4071 · Cited by 10
Current status and future prospects for the treatment of antiphospholipid syndrome
Marzooqi, A. A., Leone, A., Saleh, J. A., & Khamashta, M. A. (2016) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2016.1178573 · Cited by 10
How to manage patients with systemic lupus erythematosus who are also antiphospholipid antibody positive
Giles, I., & Rahman, A. (2009) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2009.01.009 · Cited by 11
Management of patients with antiphospholipid antibodies: what to do in laboratory scenarios that do not fit the guidelines
da Rosa, G. P., Rodríguez‐Pintó, I., Cervera, R., & Espinosa, G. (2021) · Expert Review of Hematology · doi:10.1080/17474086.2021.1923474 · Cited by 9
Pharmacologic management of neuropsychiatric lupus
Kivity, S., Baker, B., Arango, M., Chapman, J., & Shoenfeld, Y. (2015) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2016.1111137 · Cited by 9
Predictors of Mortality in Antiphospholipid Antibody–Positive Patients: Prospective Results From Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking Clinical Database and Repository
Ahmadzadeh, Y., Magder, L. S., ANDRADE, D. C. O. D., Paredes, D., Tektonidou, M. G., Pengo, V., Sciascia, S., Andréoli, L., Signorelli, F., Fortin, P. R., et al. (2025) · Arthritis Care & Research · doi:10.1002/acr.25503 · Cited by 8
The Michael Mason prize: Pathogenic antiphospholipid antibodies, stressed out antigens and the deployment of decoys
Ioannou, Y. (2011) · Lara D. Veeken · doi:10.1093/rheumatology/ker353 · Cited by 8
Thrombin generation as marker to estimate thrombosis risk in patients with abnormal test results in lupus anticoagulant routine diagnostics
Boeer, K., Cuznetov, L., & Loesche, W. (2013) · Thrombosis Journal · doi:10.1186/1477-9560-11-24 · Cited by 8
Management of the antiphospholipid syndrome
Espinosa, G., & Cervera, R. (2010) · Autoimmunity Highlights · doi:10.1007/s13317-010-0004-6 · Cited by 7
Estrategias terapéuticas en el síndrome antifosfolipídico
Cervera, R. (2009) · Reumatología Clínica · doi:10.1016/j.reuma.2008.11.020 · Cited by 8
Anticoagulants in dermatology
Inamadar, A. C., Adya, K. A., & Palit, A. (2016) · Indian Journal of Dermatology Venereology and Leprology · doi:10.4103/0378-6323.184199 · Cited by 7
Comparison of the Therapeutic Effects of Rivaroxaban Versus Warfarin in Antiphospholipid Syndrome: A Systematic Review
Khodashahi, M., REZAIEYAZDI, Z., & SAHEBARI, M. (2020) · Archives of Rheumatology · doi:10.5606/archrheumatol.2020.7375 · Cited by 8
Intensity of anticoagulation in the treatment of thrombosis in the antiphospholipid syndrome: a meta-analysis
da Silva, F. F., & de Carvalho, J. F. (2015) · Revista Brasileira de Reumatologia (English Edition) · doi:10.1016/j.rbre.2014.08.015 · Cited by 7
Treatment of Antiphospholipid Syndrome
Espinosa, G., & Cervera, R. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-374994-9.10055-5 · Cited by 7
Antiphospholipid syndrome
Khamashta, M. A., & Amigo, M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-09138-1.00139-x · Cited by 8
Antiphospholipid syndrome: long-time research on pathogenic mechanisms has finally lead to new therapeutic strategies
Cervera, R., & Espinosa, G. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.530900 · Cited by 7
A qualitative investigation of the experiences of patients living with antiphospholipid antibodies
Cardwell, F. S., Kobza, A. O., Elliott, S. J., Gibson, P., Soliman, N., Skeith, L., Clarke, A. E., & Barber, M. R. W. (2024) · Lupus · doi:10.1177/09612033241265545 · Cited by 6
Deciphering Mechanisms, Prevention Strategies, Management Plans, Medications, and Research Techniques for Strokes in Systemic Lupus Erythematosus
Al-Ewaidat, O. A., & Naffaa, M. M. (2024) · Medicines · doi:10.3390/medicines11070015 · Cited by 7
Antiphospholipid Syndrome and Kidney Involvement
Simone, E. D., Sciascia, S., Fenoglio, R., Oddone, V., Barreca, A., & Roccatello, D. (2023) · Kidney & Blood Pressure Research · doi:10.1159/000529229 · Cited by 11
Therapeutic strategies in antiphospholipid syndrome
Cervera, R. (2010) · Reumatología Clínica (English Edition) · doi:10.1016/s2173-5743(10)70007-1 · Cited by 6
Antiphospholipid Syndrome: A Challenging Hypercoagulable State with Systemic Manifestations
Donadini, M. P., & Crowther, M. A. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.05.005 · Cited by 6
Avances de interés clínico en el diagnóstico y tratamiento de los pacientes con síndrome antifosfolípido
García, J. L., & Khamashta, M. A. (2012) · Revista Clínica Española · doi:10.1016/j.rce.2012.04.003 · Cited by 6
Antithrombotic treatment for stroke associated with antiphospholipid antibodies
Arachchillage, D. J., Machin, S. J., & Cohen, H. (2014) · Expert Review of Hematology · doi:10.1586/17474086.2014.892413 · Cited by 6
Recurrent acute myocardial infarction as an initial manifestation of antiphospholipid syndrome
Smukowska-Gorynia, A., Mularek‐Kubzdela, T., & Araszkiewicz, A. (2014) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0000000000000141 · Cited by 6
Immunotherapeutic strategies in antiphospholipid syndrome
Hoi, A. Y.-B., Ross, L., Day, J., & Buchanan, R. R. C. (2016) · Internal Medicine Journal · doi:10.1111/imj.13245 · Cited by 7
The Antiphospholipid Syndrome
D’Cruz, D. P., Knight, J. S., Sammaritano, L. R., Salmon, J. E., Cervera, R., & Khamashta, M. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-23488-0_14 · Cited by 6
Síndrome antifosfolipídico en el siglo xxi
Ruiz‐Irastorza, G., Martínez-Berriotxoa, A., & Egurbide, M. V. (2009) · Medicina Clínica · doi:10.1016/j.medcli.2008.10.046 · Cited by 6
Food anaphylaxis in antiphospholipid syndrome and thrombosis
Armentia, A., Mazón, A., Pineda, F., Palácios, R., Crespo, J., Inglada, L., Martín-Santos, J. M., García‐Frade, J., & Martín-Armentia, B. (2011) · Allergologia et Immunopathologia · doi:10.1016/j.aller.2010.06.011 · Cited by 5
Antiphospholipid Syndrome
Avčin, T., & O’Neil, K. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-24145-8.00024-7 · Cited by 5
Clinical advances of interest in the diagnosis and treatment of patients with antiphospholipid syndrome
García, J. L., & Khamashta, M. A. (2013) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2012.04.001 · Cited by 5
Antiphospholipid syndrome
Abe, N., & ATSUMI, T. (2018) · Japanese Journal of Thrombosis and Hemostasis · doi:10.2491/jjsth.29.294 · Cited by 5
Coagulation Abnormalities in Stroke
Coull, B. M., & Drake, K. W. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5478-8.10041-7 · Cited by 5
Pediatric antiphospholipid syndrome: expanding our understanding of antiphospholipid syndrome in children
Lewis, K., Tambralli, A., & Madison, J. A. (2025) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000001083 · Cited by 7
Bleeding in Patients with Antiphospholipid Antibodies
Kubisz, P., Hollý, P., & Staško, J. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.97856 · Cited by 4

Authors: Ruiz‐Irastorza, G., Hunt, B. J., & Khamashta, M. A.
Affiliations: University of the Basque Country (ES)
St Thomas' Hospital (GB)
ORCID: Ruiz‐Irastorza, Guillermo
Hunt, Beverley J.
Khamashta, Munther A.
Venue: Arthritis Care & Research
Publisher: Wiley
Published: 2007-11-29
Volume: 57
Issue: 8
Pages: 1487-1495
ISSN: 0893-7524 (ISSN-L)
1529-0123
DOI: 10.1002/art.23109
OpenAlex: W2160198109
Cited by: 324
References: 40
Citations by year: 2026: 4 · 2025: 6 · 2024: 12 · 2023: 11 · 2022: 6 · 2021: 10 · 2020: 19 · 2019: 20 · 2018: 14 · 2017: 16 · 2016: 28 · 2015: 27 · 2014: 20 · 2013: 19 · 2012: 27
FWCI: 2.58
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Arthritis Care & Research (publishedVersion)
PubMed (publishedVersion)
Research Portal (King's College London) (submittedVersion)
Topics: Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Keywords: antiphospholipid antibodies, antiphospholipid syndrome, warfarin, oral anticoagulation, international normalized ratio, venous thromboembolism, arterial thrombosis, stroke, recurrent thrombosis, bleeding risk, low-dose aspirin
MeSH terms: Anticoagulants, Aspirin, Humans, Platelet Aggregation Inhibitors, Thrombosis, Warfarin, Antiphospholipid Syndrome, Antibodies, Antiphospholipid, International Normalized Ratio

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks